Should Statins Be Banned from Dialysis?

由 De Vriese, An S.
發表在 J Am Soc Nephrol (2017)

IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis

由 De Vriese, An S., Reynders, Marijke
發表在 Am J Kidney Dis (2020)

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’

由 De Vriese, An S., Reynders, Marijke
發表在 Am J Kidney Dis (2020)

Vancomycin: The Tale of the Vanquisher and the Pyrrhic Victory

由 De Vriese, An S., Vandecasteele, Stefaan J.
出版 2014

PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?

由 De Vriese, An S., Fervenza, Fernando C.
發表在 Clin J Am Soc Nephrol (2021)

P143 VALIDITY OF PULSE WAVE VELOCITY AND AUGMENTATION INDEX MEASUREMENTS IN PATIENTS WITH ATRIAL FIBRILLATION

由 Rogier Caluwe, An S. De Vriese, Bruno Van Vlem, Francis Verbeke
出版 2017-12-01

The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials

由 Caluwé, Rogier, Pyfferoen, Lotte, De Boeck, Koen, De Vriese, An S.
發表在 Clin Kidney J (2016)

Pharmacological Strategies for Manipulating Plant Ca(2+) Signalling

由 De Vriese, Kjell, Costa, Alex, Beeckman, Tom, Vanneste, Steffen
發表在 Int J Mol Sci (2018)

Portrait économique des diffuseurs d’art actuel inscrits à la Maison des artistes

由 Dominique Sagot-Duvauroux, Nathalie Moureau, Bénédicte Martin, Muriel de Vrièse

C4d as a Diagnostic Tool in Proliferative GN

由 Sethi, Sanjeev, Nasr, Samih H, De Vriese, An S., Fervenza, Fernando C.
發表在 J Am Soc Nephrol (2015)

Diffusion et valorisation de l’art actuel en région : Une étude des agglomérations du Havre, de Lyon, de Montpellier, Nantes et Rouen

由 Dominique Sagot-Duvauroux, Corinne Melin, Nathalie Moureau, Bénédicte Martin, Muriel de Vrièse

Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents

由 Van Praet, Jens T, Vandecasteele, Stefaan, De Roo, Anneleen, De Vriese, An S, Reynders, Marijke
發表在 Clin Infect Dis (2021)

Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach

由 De Vriese, An S., Sethi, Sanjeev, Van Praet, Jens, Nath, Karl A., Fervenza, Fernando C.
發表在 J Am Soc Nephrol (2015)

A Proposal for a Serology-Based Approach to Membranous Nephropathy

由 De Vriese, An S., Glassock, Richard J., Nath, Karl A., Sethi, Sanjeev, Fervenza, Fernando C.
發表在 J Am Soc Nephrol (2017)

Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach

由 De Vriese, An S., Sethi, Sanjeev, Nath, Karl A., Glassock, Richard J., Fervenza, Fernando C.
發表在 J Am Soc Nephrol (2018)

C3 Glomerulopathy: 10-Years Experience at the Mayo Clinic

由 Ravindran, Aishwarya, Fervenza, Fernando C., Smith, Richard J.H., De Vriese, An S., Sethi, Sanjeev
發表在 Mayo Clin Proc (2018)

Therapeutic trials in adult FSGS: lessons learned and the road forward

由 De Vriese, An S., Wetzels, Jack F., Glassock, Richard J., Sethi, Sanjeev, Fervenza, Fernando C.
發表在 Nat Rev Nephrol (2021)

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

由 De Vriese, An S., Caluwé, Rogier, Van Der Meersch, Hans, De Boeck, Koen, De Bacquer, Dirk
發表在 J Am Soc Nephrol (2021)

Endothelial dysfunction in diabetes

由 De Vriese, An S, Verbeuren, Tony J, Van de Voorde, Johan, Lameire, Norbert H, Vanhoutte, Paul M
出版 2000

Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia

由 Salade, Laurent, Wauthoz, Nathalie, Deleu, Magali, Vermeersch, Marjorie, De Vriese, Carine, Amighi, Karim, Goole, Jonathan
發表在 Int J Nanomedicine (2017)